Saniona Initiates Multiple Ascending Dose Stage of SAN711 Phase 1 Clinical Trial
PRESS RELEASE February 10, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on…
Year: 2022
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2
– Pseudovirus results being shared with government and regulatory authorities;publication in bioRxiv anticipated in the coming…
Nexalogy Selected to Proceed to the Next Phase of Canada’s Department of National Defence Innovation for Defence Excellence and Security Project
Toronto, Ontario–(Newsfile Corp. – February 10, 2022) – Datametrex AI Limited (TSXV: DM) (FSE: D4G)…
United States: TotalEnergies to Acquire SunPower’s Commercial & Industrial Solar Business
Enabling TotalEnergies to expand reach in the U.S. B2B solar distributed generation; SunPower to focus…
Pandemic Challenges Drive EMEA Banks to FICO AI-Powered Optimisation
Akbank, and Bank Leumi are latest lenders to build lending strategies with advanced prescriptive analytics…
Infovista launches Smart CAPEX solution to deploy and scale 5G networks that deliver maximum ROI
AI/ML-based network planning, optimization, and modelling solution to deliver mobile network with the highest revenue…
FDA accepts Dupixent® (dupilumab) for Priority Review in children aged 6 months to 5 years with moderate-to-severe atopic dermatitis
FDA accepts Dupixent® (dupilumab) for Priority Review in children aged 6 months to 5 years…
argenx to Present at the 11th Annual SVB Leerink Global Healthcare Conference
February 10, 2022 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology…
Merck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI Platform for Clinical Safety Prediction
BOSTON and TEL-AVIV, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) — Quris, an artificial intelligence (AI)…
CoStar Group Launches New ‘CoStar Impact Awards’ to Spotlight Exemplary CRE Transactions and Projects
Nominations are Open Now, With Projects and Transactions from 11 Top U.S. Markets Eligible for…
Statera Biopharma Announces Closing of $2.0 Million Registered Direct Offering
FORT COLLINS, Colo., Feb. 09, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
Medexus Pharmaceuticals Generated $21.3M in Fiscal 2022 Third Quarter Revenues and Achieved $1.9M Positive EBITDA for the Three Months Ended December 31, 2021
Achieved $21.3 million revenue driven by a recovery in IXINITY sales Treosulfan NDA resubmission expected…
Decibel Therapeutics Reports on Continued Progress of Lead Gene Therapy Product Candidate DB-OTO and Presents Promising Preclinical Data Supporting Importance of Cell-Selective Transgene Expression Across Gene Therapy Pipeline
– Podium presentation at Association for Research in Otolaryngology Annual MidWinter Meeting highlighting DB-OTO dose-ranging…
Clearmind Medicine announces Share-Based Compensation Plan
TORONTO, Feb. 09, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTCMKTS:…
Agra Ventures Records Up To $491,000 in Wholesale Cannabis Revenue in the Last Two Months
The Company has also Executed a Share Purchase Agreement to Acquire up to 34% of…
Shattuck Labs Announces Participation in Upcoming 11th Annual SVB Leerink Global Healthcare Conference
AUSTIN, TX and DURHAM, NC, Feb. 09, 2022 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck)…
Travere Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
SAN DIEGO, Feb. 09, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Active Biotech: Year End Report 2021
FOURTH QUARTER IN BRIEF In 2021, we made substantial progress in our projects to address…
Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2022
Monthly information regarding the total number of voting rights andtotal number of shares of the…
Chinook Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
SEATTLE, Feb. 09, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company…